33 results
Antiarrhythmic Medication Table

#Antiarrhythmic #Medications #Table #Classification #Classes #Cardiology #Pharmacology
Antiarrhythmic Medication ... Table #Antiarrhythmic ... #Medications #Table ... Classification #Classes ... #Cardiology #Pharmacology
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
Antianginal Drugs DRUG CLASS ... #Antianginal #Medications ... #Cardiology #Pharmacology ... #Management #Therapy ... #Table #Overview
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
FDA-Approved 1st line Medications ... , Varenicline (tablet ... ) #Pharmacology ... Tobacco #Cessation #Therapy ... #Agents #Dosing
Therapy for AL Amyloidosis 2019 
 - Antibodies (Plasma cells) 
 - Proteasome Inhibitors 
 -
Therapy for AL Amyloidosis ... ALAmyloidosis #Therapy ... #Medications #Therapies ... #Pharmacology # ... Management #Classes
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
management #algorithm #pharmacology ... #treatment #medications ... #table #pharmacotherapy ... #decisionaid #cardiology ... hematology #warfarin #dosing
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Each class of medications ... and risks, and therapy ... #pharmacology #pharmacotherapy ... #table #comparison ... #management #medications
Antiarrhythmics - Sodium Channel Blockers
Subclasses, Mechanisms, Indications, Side Effects
la - Quinidine, Procainamide
lb - Lidocaine, Mexiletine
Ic -
Subclasses, Mechanisms, Indications ... Channel #Blockers #ClassI ... #Na #cardiology ... #pharmacology # ... table #comparison
Medications Used in Congestive Heart Failure

In CHF, the heart is failing as a pump; cardiac output
Medications Used ... CHF also causes ... is chronic Drug therapy ... #Pharmacology #CHF ... #HeartFailure #Cardiology
AACE/ACE 2016 Postmenopausal Osteoporosis Treatment Algorithm

Evaluate for causes of secondary osteoporosis

Correct calcium/vitamin D deficiency and address
AACE/ACE 2016 Postmenopausal ... Evaluate for causes ... • Recommend pharmacologic ... therapy • Education ... benefits and risks of medications
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
exacerbations Drug Class ... Eosinophils < 100 Dosing ... : 250 mcg tablet ... the use of this medication ... #Pharmacology #